Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain  Renato V. Samala, MD, Rafael.

Slides:



Advertisements
Similar presentations
Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.
Advertisements

Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population Noko Mphahlele, MSc, Duncan Mitchell, PhD, Peter Kamerman,
Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain Oscar A. de Leon-Casasola, MD Journal of Pain and Symptom Management Volume.
Palliative Medicine Fellowship: A Study of Resident Choices
Eva K. Schildmann, MD, Andrew N. Davies, FRCP 
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Chronic Pain Management in Older Adults: Special Considerations
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Is Oxycodone Efficacy Reflected in Serum Concentrations
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 
The Public Health Strategy for Palliative Care
Palliative Care in Norway: A National Public Health Model
An Effective Treatment of Severe Complex Regional Pain Syndrome Type 1 in a Child Using High Doses of Intrathecal Ziconotide  Michael Stanton-Hicks, MD,
Chronic Pain Management in Older Adults: Special Considerations
A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations  Mary E. Lynch,
Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.
The opportunity for collaborative care provision: the presence of nursing home/hospice collaborations in the U.S. states  Susan C. Miller, PhD, Vincent.
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Why Now? Timing and Circumstances of Hastened Deaths
Optimization of opioid therapy for preventing incident pain associated with bone metastases  Sebastiano Mercadante, MD, Patrizia Villari, MD, Patrizia.
Psychostimulants for the Management of Cancer-Related Fatigue: A Systematic Review and Meta-Analysis  Ollie Minton, MSc, Alison Richardson, PhD, Michael.
Patricia Ann Repar, DMA, Steve Reid, MD, PhD 
Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases  Edward Chow, MBBS, Lori Davis, PhD, Lori Holden,
David M. Simpson, MD, Lydia Estanislao, MD, Stephen J
What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study  Catherine Malia, MSc, Michael I. Bennett, MB, ChB,
Barbara Strohbuecker, MScN, Herbert Mayer, Dr. rer. nat. , George C. M
The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Eduardo Bruera, MD, Raul Sala, MD, Odette Spruyt, MD, J
Geographic Variation in Hospice Use in the United States in 2002
David M. Dosa, MD, MPH, David D
The Costs and Savings of a Regional Public Palliative Care Program: The Catalan Experience at 18 Years  Silvia Paz-Ruiz, MD, Xavier Gomez-Batiste, MD,
How to Measure the International Development of Palliative Care
Metastatic Breast Cancer Causing Gas Gangrene
What Can We Learn About the Spiritual Needs of Palliative Care Patients From the Research Literature?  Mark Cobb, MA, Christopher Dowrick, MD, FRCGP,
Eugene Murray, BBS, MLitt (Econ) 
Parent Perceptions of Child Vulnerability Are Associated With Functioning and Health Care Use in Children With Chronic Pain  Mark Connelly, PhD, Kelly.
David Clark, PhD, Michael Wright, PhD 
Redefining Appropriate Treatment Expectations
Amy Z. Boelk, PhD, MSSW, Betty J. Kramer, PhD, MSSW 
Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study  Kim Fisher, PhD, Carla Stiles,
Errors in Opioid Prescribing: A Prospective Survey in Cancer Pain
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
A Comparative Review of Palliative Care Development in Six Countries Represented by the Middle East Cancer Consortium (MECC)  Amanda Bingley, PhD, David.
Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD 
Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD 
U.S. Hospice Benefits Journal of Pain and Symptom Management
Use of Opioid Analgesics Among Older Persons With Colorectal Cancer in Two Health Districts With Palliative Care Programs  Judith Fisher, BSc (Pharm),
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS)  G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,
Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center  J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH 
Margot E. Kurtz, PhD, Jay C. Kurtz, PhD, Charles W
Tomoyuki Kawada, MD  Journal of Pain and Symptom Management 
Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review  Steffen T. Simon, MD, MSc, Peyla Köskeroglu, Jan Gaertner, MD, Raymond Voltz,
Perceived Success in Addressing End-of-Life Care Needs of Low-Income Elders and Their Families: What Has Family Conflict Got to Do With It?  Betty J.
A Meta-Analysis of the Relationship Between Response Expectancies and Cancer Treatment-Related Side Effects  Stephanie J. Sohl, PhD, Julie B. Schnur,
Ketamine Use for Reduction of Opioid Tolerance in a 5-Year-Old Girl with End-Stage Abdominal Neuroblastoma  Doralina L. Anghelescu, MD, Linda L. Oakes,
Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain  Philippe Poulain, MD,
Coping Strategies in the Presence of One's Own Impending Death from Cancer  Lisa Sand, MSW, PhD (C), Mariann Olsson, MSW, PhD, Peter Strang, MD, PhD  Journal.
Botucatu, Brazil: A Regional Community Palliative Care Model
Amy P. Abernethy, MD  Journal of Pain and Symptom Management 
Optimizing Decision Making and Resource Allocation in Palliative Care
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals  Jane Hopkinson, PhD, RGN, Jessica.
Cancer Symptom Clusters: A Validation Study
Associations Between Physical Activity and Quality of Life in Cancer Patients Receiving Palliative Care: A Pilot Survey  Sonya S. Lowe, MD, MSc, Sharon.
Physical Activity Behaviors in Individuals with Multiple Sclerosis: Roles of Overall and Specific Symptoms, and Self-Efficacy  Erin M. Snook, MS, Robert.
Opioid Equianalgesic Tables: Are They All Equally Dangerous?
Nontraumatic Subcutaneous Emphysema from Rectal Cancer Perforation Completely Resolved After Intensive Pain Control  Tatsuya Morita, MD, Takeru Matsuda,
Presentation transcript:

Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain  Renato V. Samala, MD, Rafael Bloise, MD, Mellar P. Davis, MD  Journal of Pain and Symptom Management  Volume 48, Issue 1, Pages 132-136 (July 2014) DOI: 10.1016/j.jpainsymman.2013.09.001 Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 1 Median pain intensity ratings before TF placement (zero hours) and six, 12, 18, and 24 hours thereafter. TF=transdermal fentanyl. Journal of Pain and Symptom Management 2014 48, 132-136DOI: (10.1016/j.jpainsymman.2013.09.001) Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 2 Median number of rescue analgesic doses before TF placement (zero hours) and six, 12, 18, and 24 hours thereafter. TF=transdermal fentanyl. Journal of Pain and Symptom Management 2014 48, 132-136DOI: (10.1016/j.jpainsymman.2013.09.001) Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.